Results
|
181.
|
|
|
182.
|
|
|
183.
|
|
|
184.
|
|
|
185.
|
|
|
186.
|
|
|
187.
|
|
|
188.
|
|
|
189.
|
|
|
190.
|
|
|
191.
|
|
|
192.
|
|
|
193.
|
Retrospective study of predictive variables for maximal heart rate (HRmax) in horses undergoing strenuous treadmill exercise. [electronic resource] by
- Vincen, T L
- Newton, J R
- Deaton, C M
- Franklin, S H
- Biddick, T
- McKeever, K H
- McDonough, P
- Young, L E
- Hodgson, D R
- Marlin, D J
Producer: 20070502
In:
Equine veterinary journal. Supplement no. 36
Availability: No items available.
|
|
194.
|
ARMS allele-specific amplification-based detection of mutant p53 DNA and mRNA in tumors of the breast. [electronic resource] by
- Hodgson, D R
- Clayton, S J
- Girdler, F
- Brotherick, I
- Shenton, B
- Browell, D
- Stuart, M
- Fox, J C
- Ceuppens, P
- Foy, C A
- Whitcombe, D
- Gibson, N J
Producer: 20010419
In:
Clinical chemistry vol. 47
Availability: No items available.
|
|
195.
|
PD-L1 and immune infiltrates are differentially expressed in distinct subgroups of gastric cancer. [electronic resource] by
- Angell, H K
- Lee, J
- Kim, K-M
- Kim, K
- Kim, S-T
- Park, S H
- Kang, W K
- Sharpe, A
- Ogden, J
- Davenport, A
- Hodgson, D R
- Barrett, J C
- Kilgour, E
Publication details: Oncoimmunology
In:
Oncoimmunology vol. 8
Availability: No items available.
|
|
196.
|
Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced non-small-cell lung cancer. [electronic resource] by
- Jänne, P A
- Smith, I
- McWalter, G
- Mann, H
- Dougherty, B
- Walker, J
- Orr, M C M
- Hodgson, D R
- Shaw, A T
- Pereira, J R
- Jeannin, G
- Vansteenkiste, J
- Barrios, C H
- Franke, F A
- Crinò, L
- Smith, P
Producer: 20150930
In:
British journal of cancer vol. 113
Availability: No items available.
|